Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01893892 · ClinicalTrials.gov registry record · NA
Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01893892: Completed NA study, sponsored by Stanford University.
NCT01893892 is a NA study that has completed, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01893892, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.
Interventions
- OTHER placebo
- OTHER questionnaire administration
- DIETARY_SUPPLEMENT levocarnitine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-03 |
| Est. Completion | 2017-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01893892
The ClinicalTrials.gov registry entry for NCT01893892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01893892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01893892 about?
NCT01893892 is a clinical study titled "Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms". This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.
What is the current status of trial NCT01893892?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-03. Estimated completion is 2017-03-15.
What interventions are being tested in trial NCT01893892?
The interventions under investigation include: placebo (OTHER), questionnaire administration (OTHER), levocarnitine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01893892?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.